KSB releases transcript of August 19 institutional investor meet
- KSB released the transcript of its August 19, 2026 institutional investor meet
- H1FY26 revenue reached ₹12,920 million with EBITDA of ₹1,465 million
- Nuclear order book stands at ₹1,235 crore with testing resuming in September
- Export challenges easing as supply chain stability improves to 85-90%
- Solar revenue impacted by KUSUM 2.0 delays; valves margins under pressure

*this image is generated using AI for illustrative purposes only.
KSB Limited has released the full transcript of its institutional investor meet held on August 19, 2026. The company previously shared a video recording of the event, which was organized by ICICI Securities in Mumbai.
The transcript, dated August 26, 2026, provides detailed insights into the company’s financial performance and operational updates for the first half of FY26. Management discussed key growth drivers, including the nuclear energy segment, data centre applications, and export market dynamics.
Event Details
| Detail | Information |
|---|---|
| Date | August 19, 2026 |
| Mode | Physical at Mumbai |
| Format | One-on-one / Group |
| Organizer | ICICI Securities |
The session included presentations by Mr. Rajeev Jain (Managing Director), Mr. Mahesh Bhave (Chief Financial Officer), and Mr. Nitin Patil (Vice President for IPD/EPD Operations and COO, Nuclear Business). Registrations were handled by ICICI Securities representatives.
Financial Highlights
Management highlighted that revenue from operations grew at a 17% CAGR, while profit after tax expanded at a 22% CAGR. For the half-year ended June 2026, the company reported revenue from sales of ₹12,920 million, EBITDA of ₹1,465 million, and profit before tax of ₹1,279 million. Return on capital employed stood at 22.8%, excluding one-time labour code impacts.
Nuclear Business Update
Mr. Nitin Patil provided updates on the nuclear division, noting an order book of ₹1,235 crore. This includes pumps for GHAVP 1 and 2, Kaiga 5 and 6, and safety packages for Kudankulam. Testing for GHAVP pumps faced delays due to issues with NPCIL’s test bed but is expected to resume in September. The company recently expanded its Shirwal plant capacity by 20% to meet future demand.
Export and Supply Chain
Exports faced headwinds in H1 due to geopolitical tensions and supply chain disruptions, particularly in the Middle East. Management noted that supply chain stability has improved to 85-90%, with revised price agreements in place. Export orders currently constitute approximately 15% of the total order book, with a target of 20%.
Other Segments
Solar revenue was lower than expected due to delays in the KUSUM 2.0 scheme, contributing ₹50-60 crore in H1. The valves segment saw margin compression to single digits due to commodity prices and product mix, which management expects to normalize. SupremeServ aftermarket business continues to grow at 15% annually.
Historical Stock Returns for KSB
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -0.79% | +0.04% | +5.64% | -1.40% | 0.0% |
How will the 20% capacity expansion at the Shirwal plant impact KSB's ability to capture emerging nuclear orders beyond the current ₹1,235 crore book?
What specific strategies is management implementing to increase the export order book share from 15% to the targeted 20% amidst lingering geopolitical risks?
Could the normalization of margins in the valves segment offset potential revenue shortfalls from delays in the KUSUM 2.0 solar scheme in FY27?


































